Hormone therapy for breast cancer lowers estrogen or blocks its effects to treat hormone receptor-positive tumors, which the National Cancer Institute says make up about 80% of breast cancer diagnoses. As of November 2026 no federal mass tort targets these drugs: the JPML's November 2, 2026 pending-docket report lists none for tamoxifen, aromatase inhibitors or similar medicines.
Updates on Hormone Therapy for Breast Cancer
Discover how hormone therapy breast cancer treatment works, who qualifies, and how to manage side effects for better outcomes.
Key facts (as of November 2026)
- Nov. 2, 2026: No MDL for breast cancer hormone therapy appears on the JPML's report.
- Nov. 2, 2026: Depo-Provera contraceptive litigation (MDL 3140) listed 6,413 pending actions.
- Nov. 2, 2026: Hair relaxer litigation (MDL 3060) listed 12,743 pending actions.
- Sept. 2026: NCI's updated fact sheet says 5 or more years of hormone therapy can greatly reduce recurrence risk.
What hormone therapy is
NCI groups the main options as ovarian suppression, aromatase inhibitors (anastrozole, letrozole, exemestane), tamoxifen and fulvestrant. The most common side effects are hot flashes, night sweats and loss of interest in sex.
Is there a hormone therapy lawsuit?
Not a mass tort. Related legal questions involve delayed or missed breast cancer diagnosis, a medical malpractice issue, or separate hormone-related product litigation such as Depo-Provera and hair relaxers.
Who may have a claim
People whose diagnosis was delayed, or who were harmed by one of those separate products, may have claims under state law or the relevant MDL.
Deadlines and next steps
Deadlines vary by state and can be short. Never stop prescribed therapy without your oncologist.
Frequently asked questions
Can I sue over tamoxifen or aromatase inhibitor side effects?
No coordinated mass tort covers these drugs as of November 2026. Legal questions tied to breast cancer care can instead involve how care was delivered, such as a delayed or missed diagnosis, which is governed by state malpractice law and its own deadlines. An attorney can assess a specific situation.
How long is hormone therapy usually taken?
NCI says taking hormone therapy for 5 years or more can greatly reduce the risk of recurrence. One common approach is tamoxifen for 2 to 3 years followed by an aromatase inhibitor for 2 to 3 years. Your oncologist sets the plan based on menopausal status and tumor features.
Is Depo-Provera hormone therapy?
Not in the breast cancer sense. Depo-Provera is a hormonal contraceptive injection, not a breast cancer treatment. MDL 3140 in the Northern District of Florida involves claims that it caused intracranial meningioma and listed 6,413 pending actions on November 2, 2026. TortAdvisor covers it in a separate guide.
Sources
Your deadline runs even while an MDL is pending
Joining a mass tort still requires filing your own case on time. State statutes of limitations usually keep running while bellwether trials and settlement talks go on.
Free · Confidential · No obligation
Free Hormone Therapy Case Review
Tell us what happened and a trained case advisor will review it. You choose whether you want to be contacted.
- 1Share the basicsThe product, your injury and the dates.
- 2A case advisor reviews itAgainst the criteria in active mass torts.
- 3You decide what happens nextNo cost and no obligation.
- Live case countsFrom the JPML monthly report
- Every answer is citedEach answer links its primary source
- Free and confidentialNo cost and no obligation to continue
- Not a law firmA trained case advisor makes the first contact
Prefer to talk it through?
TortAdvisor is not a law firm and does not give legal advice. A trained case advisor, not an attorney, may make the first contact. See our partner list and privacy policy.
Filter Posts
Browse by Category
